Friday, July 11, 2025
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
    Unlocking the Secrets of GLP-1 Medications

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
    Navigating the Medical Licensing Maze

    Navigating the Medical Licensing Maze

    April 4, 2025
    The Alarming Truth About Health Insurance Denials

    The Alarming Truth About Health Insurance Denials

    February 3, 2025
    Telehealth in Turmoil

    The Importance of NIH Grants

    January 31, 2025
  • Surveys

    Surveys

    What concerns you most about your healthcare?

    What concerns you most about your healthcare?

    July 1, 2025
    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    June 4, 2025

    Survey Results

    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
    Unlocking the Secrets of GLP-1 Medications

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
    Navigating the Medical Licensing Maze

    Navigating the Medical Licensing Maze

    April 4, 2025
    The Alarming Truth About Health Insurance Denials

    The Alarming Truth About Health Insurance Denials

    February 3, 2025
    Telehealth in Turmoil

    The Importance of NIH Grants

    January 31, 2025
  • Surveys

    Surveys

    What concerns you most about your healthcare?

    What concerns you most about your healthcare?

    July 1, 2025
    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    June 4, 2025

    Survey Results

    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Much Ado About Aduhelm

Daily Remedy by Daily Remedy
March 27, 2022
in Politics & Law
0
Much Ado About Aduhelm

Truth, according to philosopher Immanuel Kant, is not a set of objective facts. It is not logical consistency either. As Kant wrote, it is an “agreement of cognition”, a state where facts and logic coalesce into a belief.

While Kant has mostly been relegated to the annals of philosophical theory, his treatise on truth remains applicable today in healthcare, particularly as it concerns the embattled Alzheimer’s drug, Aduhelm.

“We are pleased that the peer-reviewed manuscript is now available to provide physicians with a greater understanding of the appropriate use of Aduhelm,” said Samantha Haeberlein, Head of Neurodegeneration Development at the biotechnology firm, Biogen, which manufactures the drug.

The study, published in mid-March, monitored patients with Alzheimer’s disease for over two years to demonstrate the clinical benefits of Aduhelm – though the FDA has already approved it in 2021 as a form of treatment. Despite existing data and FDA approval, many physicians still do not understand how the drug confers any actual benefit to patients. To which Biogen responded with additional data.

But the study does little to address the original misunderstanding – does the drug address the symptoms of patients with Alzheimer’s disease – and instead continues to claim clinical benefits in the most abstruse of ways.

Biogen says Aduhelm treats Alzheimer’s disease by reducing the levels of proteins in the brain associated with the disease, the most well-known being tau-amyloid, though other forms of amyloid proteins are involved as well. By reducing these proteins, Biogen claims the drug treats dementia. Preliminary data proved that protein concentrations reduced when patients took the drug, but physicians were unsure of how that benefited the clinical progression of the disease symptomatically.

This latest study tries to clarify the relationship between lower amyloid protein concentrations and symptomatic improvements. They followed patients in the original study for an additional two years, monitoring for clinical changes. Even with the prolonged period, the authors selected a bizarrely precise point in time to prove that the drug indeed slows the progression of Alzheimer’s disease.

Specifically, at week 78, patients who showed a reduction in the amyloid proteins had slower clinical progression across all measurements of cognition function in the study. And patients who had reduced amyloid levels at week 78 also had greater decreases in week 128.

By that logic, Biogen would have you believe that Aduhelm provides clinical benefits to patients with severe Alzheimer’s disease. The data has repeatedly shown to reduce amyloid protein concentrations. Since the patho-physiology of dementia involves a buildup of these proteins in the brain, it would appear the facts and logic are in agreement – meeting the Kantian requirements of truth.

But truth in medicine can be tricky. It is a world where facts can rapidly descend into fiction and theories once taboo can quickly gain mainstream credibility. In reality, there are no causal relationships in healthcare. Everything is correlative, which means they are usually true, but not always. And it is this inconsistency that gives every assumed truth just enough error to be questioned.

Previous studies that have examined the relationship between amyloids proteins in the cognitively impaired, and the degree of impairment, suggest that elevated protein concentrations are associated with cognitive decline, but the strength of association differs based on cognitive status and the duration of follow-up.

This makes the oddly precise dates of 78 and 128 weeks tantalizingly deceptive. The dates selected seem deliberate; almost a willful attempt to create the impression that Aduhelm stops the progression of dementia. What if we select a different set of dates, or continue the study even longer?

Any clinical study with a long term follow-up, known as a longitudinal study, can be manipulated to present any predetermined outcome. All you need to do is select the right time horizon – like an oddly precise number of weeks – to demonstrate a particular outcome in the trending data, regardless of whether it is a statistical aberration or a clinically meaningful relationship.

This is why longitudinal studies hardly ever conclude with causal relationships; the trends are always correlative, always appearing with just enough error to remind that correlation is not causation. And like many appearances, it can be deceiving, like Biogen’s latest clinical study.

It tries to show how Aduhelm treats Alzheimer’s disease, but in reality it shows how easily data can be manipulated.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

In this episode of the Daily Remedy Podcast, Dr. Jeffrey Singer discusses his book 'Your Body, Your Health Care,' emphasizing the importance of patient autonomy in healthcare decisions. He explores historical cases that shaped medical ethics, the contradictions in harm reduction policies, and the role of the FDA in drug approval processes. Dr. Singer critiques government regulations that infringe on individual autonomy and advocates for a healthcare system that respects patients as autonomous adults. The conversation highlights the need for a shift in how healthcare policies are formulated, focusing on individual rights and self-medication.

Chapters

00:00 Introduction to Dr. Jeffrey Singer and His Book
01:11 The Importance of Patient Autonomy
10:29 Contradictions in Harm Reduction Policies
20:48 The Role of the FDA in Drug Approval
30:21 Certificate of Need Laws and Their Impact
39:59 The Legacy of Patient Autonomy and the Hippocratic Oath
Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer
YouTube Video _IWv1EYeJYQ
Subscribe

RFK Jr.’s Overhaul of CDC Vaccine Policy

Visuals

Official MAHA Report

Official MAHA Report

by Daily Remedy
May 31, 2025
0

Explore the official MAHA Report released by the White House in May 2025.

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • Generative Scribes and Pervasive Errors: The Promise and Pitfalls of AI-Driven Clinical Notes

    0 shares
    Share 0 Tweet 0
  • The First FBI Agent I Met

    3 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • Continuous Care, Continuous Data: How AI-Powered Remote Monitoring Redefines Diagnostics

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2025 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2025 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do